FDA Approves Tzield to Delay Onset of Stage 3 Type 1 Diabetes in Young Children
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
The FDA has approved a treatment called Tzield to delay the onset of stage 3 type 1 diabetes in young children. This approval is for a specific patient population, namely young children. The treatment is intended to postpone the progression of the disease to stage 3 in this group.